<?xml version="1.0" encoding="UTF-8"?>
<ref id="B35">
 <label>35.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hong</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Dobrovolskaia</surname>
    <given-names>MA</given-names>
   </name>
  </person-group>. 
  <article-title>Addressing barriers to effective cancer immunotherapy with nanotechnology: achievements, challenges, and roadmap to the next generation of nanoimmunotherapeutics</article-title>. 
  <source>Adv Drug Deliv Rev</source>. (
  <year>2019</year>) 
  <volume>141</volume>:
  <fpage>3</fpage>â€“
  <lpage>22</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.addr.2018.01.005</pub-id>
  <?supplied-pmid 29339144?>
  <pub-id pub-id-type="pmid">29339144</pub-id>
 </mixed-citation>
</ref>
